期刊文献+

肝癌相关抗原SMP-30基因工程菌培养条件的优化

THE OPTIMAL CULTURE CONDITIONS FOR PREPARING RECOMBINANT HUMAN HEPATOCELLULAR CARCINOMA-ASSOCIATED ANTIGEN SMP-30 EXPRESSED IN ENGINEERING E.COLI
下载PDF
导出
摘要 目的:对重组人肝癌相关抗原SMP-30基因工程菌的培养条件进行研究,确定最佳培养方案以提高基因工程蛋白表达产量。方法:通过SDS-PAGE蛋白质电泳和电泳图谱扫描来分析诱导剂浓度、诱导起始时间、诱导时间长短、培养温度和培养基成分对基因工程菌TB1表达肝癌相关抗原SMP-30的影响。结果:当工程菌培养条件合适,即在吸光度值A600为0.5左右时加入IPTG至终浓度0.5mmol/L,30℃培养7h,其表达的SMP-30融合蛋白可占细体总蛋白量的46.1%。将工程菌培养温度从37℃降到30℃时,表达蛋白质的可溶性部分可提高10%-15%。结论:通过对重组人肝癌相关抗原SMP-30基因工程菌的培养条件进行优化,获得较满意的应用工程菌表达肝癌相关抗原SMP-30的培养条件,为基因工程下游技术奠定了基础。 Objective: To gain the best recombinant protein expression for generation of human hepatocellular carcinoma-associated antigen SMP-30, the culture conditions of the genetic engineering E. coli (pMAL- C2-SMP-30/TB1) were investigated. Methods: Some parameters involved in the relative amounts of expressed protein were displayed and compared by using SDS-PAGE and Electrophoresis Scanning Software. The concerned factors were concentration of IPTG, the time point of induction, the time course of induction, the temperature and the components of culture medium. Results: Expression level of SMP-30 fusion proteins was as high as 46.1 % when the culture conditions were optimal. The optimal culture condition is as follows: the final concentration of IPTG in the LB medium with 0.2% glucose was 0.5 retool/L, IPTG was added when the OD600 reached approximately 0.5 and the flask was incubated for another seven hours in the 30℃ shaking airbath. The part of dissoluble protein expressed could be increased 10%-15% when the temperature was lowered from 37℃ to 30℃. Conclusion: The culture conditions for preparing recombinant human hepatocellular carcinoma associated antigen SMP-30 have been established.
出处 《广西医科大学学报》 CAS 北大核心 2007年第4期517-520,共4页 Journal of Guangxi Medical University
基金 广西自然科学基金项目(No.桂科自0339047)
关键词 肝癌相关抗原 SMP-30 基因工程菌 表达 优化 human hepatocellular carcinoma-associated antigen SMP-30 genetic engineering bacteria expression optimum
  • 相关文献

参考文献10

  • 1罗国容,谢小薰,陈维平,廖共山,韦长元.衰老标记蛋白-30——一种新的肝细胞癌相关抗原[J].广西医科大学学报,1999,16(2):115-117. 被引量:14
  • 2Ishigami T,Fujita T,Simbula G,et al.Regulatory effects of senescence marker protein-30 on the proliferation of hepatocytes.Pathol Int,2001,51(7):491-497.
  • 3SuFang Zhou,XiaoXun Xie,YeHong Bin,et al.Identification of SMP-30 tumor-associated antigen and antibody response in patients.Clinica Chimica Acta,2006,366(1-2):274-280.
  • 4周素芳,谢小薰,蓝玲,赵飞兰,黎鹏,范容,罗国容.肝癌相关抗原SMP-30羧基端基因的构建、表达及血清学分析[J].中国免疫学杂志,2004,20(12):821-824. 被引量:8
  • 5Routzahn KM,Waugh DS.Differential effects of supplementary affinity tags on the solubility of MBP fusion proteins.J Struct Funct Genomics,2002,2(2):83-92.
  • 6Guan M,Su B,Ye C,et al.Production of extracellular domain of human tissue factor using maltose-binding protein fusion system.Protein Expr Purif,2002,26(2):229-234.
  • 7Mari YM,Espinosa AE,Ubieta R,et al.Effect of the selection marker on the viability and plasmid stability of two human proteins with neurotrophic action expressed in Escherichia coli.Biochem Biophys Res Commun,1999,258:29-31.
  • 8Kim CH,Lee JY,Kim MG.Fermentation strategy to enhance plasmid stability during the cultivation of Escherichia coli for the production of recombinant levansucrase.J Ferm Bioeng,1998,86:391-394.
  • 9陈冬瑛,朱全胜,刘超,丘钜世.人骨肉瘤细胞株中骨形态发生蛋白-1的检测、克隆和表达[J].中国病理生理杂志,2003,19(6):751-756. 被引量:1
  • 10方海林,张立煌,孙永良,姚航平,林舜华,李敏伟.表达人 HGF/MBP 融合蛋白的 pMAL-MBP/HGF 重组质粒的构建及鉴定[J].中国免疫学杂志,1997,13(3):135-135. 被引量:1

二级参考文献21

  • 1Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities[ J]. Science,1988, 242(4885) : 1528- 1534.
  • 2Scott IC, Blitz IL, Pappano WN, et al. Mammalian BMP-1/Tolloid- related metalloproteinases, including novel family member mammalian Tolloid - like 2, have differential enzymatic activities and distributions of expression relevant to patteming and skeletogenesis[J]. Dev Biol, 1999, 213(2) : 283 --300.
  • 3Takahara K, Lyons GE, Greenspan DS. Bone morphogenetic protein- 1 and a mammalian tolloid homologue (mTld) are encoded by alternatively spliced transcripts which are differentially expressed in some tissues[J]. J Biol Chem, 1994, 269(51):32572 - 32578.
  • 4Kessler E, Takahara K, Biniaminov L, et al. Bone morphogenetic protein- 1 : the type I procollagen C - proteinase[J].Science, 1996, 271(5247) : 360- 362.
  • 5Uzel MI, Shih SD, Gross H, et al. Molecular events that contribute to lysyl oxidase enzyme activity and insoluble collagen accumulation in osteosarcoma cell clones [ J ]. J Bone Miner Res, 2000,15(6): 1189- 1197.
  • 6Laure Garrigue Antar, Catherine Barker, Karl E. Kadler. Identification of amino acid residues in bone morphogenetie pro-tein- 1 important for procollagen C- proteinase activity[ J]. J Biol Chem, 2001, 276(28): 26237-26242.
  • 7Imamura Y, Steiglitz BM, Greenspan DS. Bone morphogenetic protein- 1 processes the NH2 - temainal propeptide, and a furin- like proprotein convertase processes the COOH- temai-nal propeptide of pro- alphal(V) collagen[J]. J Biol Chem,1998, 273(42):27511 - 27517.
  • 8Scott IC, Imamura Y, Pappano WN, et al. Bone morpho-genetic protein- 1 processes probiglycan[ J]. J Biol Chem,2000, 275(39) : 30504- 30511.
  • 9Larrain J, Bachiller D, Lu B, et al. BMP- binding modules in chordin: a model for signalling regulation in the extracellular space[J]. Development, 2000, 127(4) : 821 - 830.
  • 10Lee S, Solow Cordem DE, Kessler E, et al. Transforming growth factor- beta regulation of bone morphogenetic protein- 1/procollagen C- proteinase and related proteins in fibrogenic ceils and keratinocytes[J]. J Biol Chem, 1997, 272(30) : 19059 - 19066.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部